Combating multidrug-resistant Plasmodium falciparum malaria

© 2017 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. Over the past 50 years, Plasmodium falciparum has developed resistance against all antimalarial drugs used against it: chloroquine, sulphadoxine–pyrimethamine, qui...

Full description

Saved in:
Bibliographic Details
Main Authors: Aung Myint Thu, Aung Pyae Phyo, Jordi Landier, Daniel M. Parker, François H. Nosten
Other Authors: Mahidol University
Format: Review
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/41824
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
id th-mahidol.41824
record_format dspace
spelling th-mahidol.418242019-03-14T15:02:50Z Combating multidrug-resistant Plasmodium falciparum malaria Aung Myint Thu Aung Pyae Phyo Jordi Landier Daniel M. Parker François H. Nosten Mahidol University University of Oxford Biochemistry, Genetics and Molecular Biology © 2017 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. Over the past 50 years, Plasmodium falciparum has developed resistance against all antimalarial drugs used against it: chloroquine, sulphadoxine–pyrimethamine, quinine, piperaquine and mefloquine. More recently, resistance to the artemisinin derivatives and the resulting failure of artemisinin-based combination therapy (ACT) are threatening all major gains made in malaria control. Each time resistance has developed progressively, with delayed clearance of parasites first emerging only in a few regions, increasing in prevalence and geographic range, and then ultimately resulting in the complete failure of that antimalarial. Drawing from this repeated historical chain of events, this article presents context-specific approaches for combating drug-resistant P. falciparum malaria. The approaches begin with a context of drug-sensitive parasites and focus on the prevention of the emergence of drug resistance. Next, the approaches address a scenario in which resistance has emerged and is increasing in prevalence and geographic extent, with interventions focused on disrupting transmission through vector control, early diagnosis and treatment, and the use of new combination therapies. Elimination is also presented as an approach for addressing the imminent failure of all available antimalarials. The final drug resistance context presented is one in which all available antimalarials have failed; leaving only personal protection and the use of new antimalarials (or new combinations of antimalarials) as a viable strategy for dealing with complete resistance. All effective strategies and contexts require a multipronged, holistic approach. 2018-12-21T06:45:08Z 2019-03-14T08:02:50Z 2018-12-21T06:45:08Z 2019-03-14T08:02:50Z 2017-08-01 Review FEBS Journal. Vol.284, No.16 (2017), 2569-2578 10.1111/febs.14127 17424658 1742464X 2-s2.0-85021720650 https://repository.li.mahidol.ac.th/handle/123456789/41824 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85021720650&origin=inward
institution Mahidol University
building Mahidol University Library
continent Asia
country Thailand
Thailand
content_provider Mahidol University Library
collection Mahidol University Institutional Repository
topic Biochemistry, Genetics and Molecular Biology
spellingShingle Biochemistry, Genetics and Molecular Biology
Aung Myint Thu
Aung Pyae Phyo
Jordi Landier
Daniel M. Parker
François H. Nosten
Combating multidrug-resistant Plasmodium falciparum malaria
description © 2017 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. Over the past 50 years, Plasmodium falciparum has developed resistance against all antimalarial drugs used against it: chloroquine, sulphadoxine–pyrimethamine, quinine, piperaquine and mefloquine. More recently, resistance to the artemisinin derivatives and the resulting failure of artemisinin-based combination therapy (ACT) are threatening all major gains made in malaria control. Each time resistance has developed progressively, with delayed clearance of parasites first emerging only in a few regions, increasing in prevalence and geographic range, and then ultimately resulting in the complete failure of that antimalarial. Drawing from this repeated historical chain of events, this article presents context-specific approaches for combating drug-resistant P. falciparum malaria. The approaches begin with a context of drug-sensitive parasites and focus on the prevention of the emergence of drug resistance. Next, the approaches address a scenario in which resistance has emerged and is increasing in prevalence and geographic extent, with interventions focused on disrupting transmission through vector control, early diagnosis and treatment, and the use of new combination therapies. Elimination is also presented as an approach for addressing the imminent failure of all available antimalarials. The final drug resistance context presented is one in which all available antimalarials have failed; leaving only personal protection and the use of new antimalarials (or new combinations of antimalarials) as a viable strategy for dealing with complete resistance. All effective strategies and contexts require a multipronged, holistic approach.
author2 Mahidol University
author_facet Mahidol University
Aung Myint Thu
Aung Pyae Phyo
Jordi Landier
Daniel M. Parker
François H. Nosten
format Review
author Aung Myint Thu
Aung Pyae Phyo
Jordi Landier
Daniel M. Parker
François H. Nosten
author_sort Aung Myint Thu
title Combating multidrug-resistant Plasmodium falciparum malaria
title_short Combating multidrug-resistant Plasmodium falciparum malaria
title_full Combating multidrug-resistant Plasmodium falciparum malaria
title_fullStr Combating multidrug-resistant Plasmodium falciparum malaria
title_full_unstemmed Combating multidrug-resistant Plasmodium falciparum malaria
title_sort combating multidrug-resistant plasmodium falciparum malaria
publishDate 2018
url https://repository.li.mahidol.ac.th/handle/123456789/41824
_version_ 1763489218784395264